The exact incidence of haemorrhoidal disease is difficult to quantify due to differences in healthcare access. In the US, the prevalence is approximately 4%[1] and is more common in white patients than in black patients, with presentation peaking between the ages of 45-65 years. Since the second half of the 20th century, there appears to be an unexplained decrease in the prevalence of symptomatic haemorrhoidal disease in both the US and England.[2]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer